A PSMA PET/CT scan is an advanced nuclear medicine test designed to locate prostate cancer cells throughout the body. PSMA stands for Prostate-Specific Membrane Antigen, a protein found in high amounts on the surface of prostate cancer cells.
During the scan, a radioactive PSMA-targeted tracer is injected into a vein. The PET/CT scanner maps tracer uptake and anatomy. Many prostate cancers show high uptake, but benign tissues and some other diseases can also take up tracer, while some prostate cancers show little or no uptake.
Common Indications for a PSMA PET/CT Scan
- Staging high-risk prostate cancer before starting treatment (surgery or radiation).
- Locating areas of cancer recurrence in patients who have rising blood test results (PSA) after past treatments.
- Determining if prostate cancer has spread to distant bones or lymph nodes.
- Planning targeted radiation therapy or surgery by pinpointing exact tumor locations.
- Assessing treatment response in selected settings when the oncology team considers the result clinically useful.
What exactly does a PSMA PET/CT scan show?
The scan combines anatomy from CT with PSMA-targeted tracer uptake from PET. It can reveal disease not seen on conventional imaging, but small deposits may remain below resolution and uptake alone does not prove that a focus is prostate cancer.
How should I prepare for a PSMA PET/CT scan?
Preparation depends on the tracer and center. You will commonly be asked to hydrate and empty your bladder shortly before imaging, but follow the written instructions from your center rather than a fixed volume or fasting rule.
Do I need to stop taking medication?
Do not stop treatment on your own. Give the imaging team a complete medicine and treatment history, including androgen-deprivation therapy, chemotherapy, radiotherapy, surgery, and dates of recent treatment, because these can affect interpretation and timing.
What happens when I arrive for my scan?
You will go to the PET center. A nurse will place an intravenous (IV) line in your arm and inject the PSMA tracer. You will sit quietly in a comfortable reclining chair for about 60 minutes to allow the tracer to distribute through your body. You should avoid moving or talking during this uptake period.
How is the procedure performed?
You will lie flat on your back on the scanner table. The table will slide slowly through the ring-shaped PET/CT scanner. The scanner will capture both CT and PET images. You must remain completely still. You may be asked to hold your breath briefly.
How long does a PSMA PET/CT scan take?
The scanning portion takes about 20 to 30 minutes. However, including the 60-minute tracer uptake waiting time, your visit will take about 2 hours.
Is there any discomfort?
The scan itself is usually painless apart from the IV needle. Most people do not feel the tracer circulating. Reactions are uncommon, but tell the team promptly if you feel unwell.
Are there risks?
The tracer and CT both contribute radiation; the total varies with the radiopharmaceutical and whether CT is low-dose or diagnostic. Hydration and bladder-emptying advice should come from the imaging team, especially if you have fluid restrictions.
Can children have this scan?
This scan is designed specifically for prostate cancer, which affects adult men. It is not performed on children.
What contact precautions apply afterward?
The team may give short-term instructions about close contact with pregnant people or young children. These depend on the tracer, administered activity, and local radiation-safety assessment; obtain them in writing.
When will I get my results?
A nuclear medicine specialist will analyze the PET/CT scans. A detailed report will be sent to your referring doctor (usually a urologist or oncologist) within 24 to 48 hours.
What if the scan finds something?
Your oncology team will interpret the scan together with PSA trends, pathology, previous treatment, and other imaging. A suspicious focus may change management, need correlation, or occasionally require further investigation rather than being treated as cancer automatically.
What are the important limitations and safety checks?
PSMA uptake is not unique to prostate cancer: normal organs, benign bone change, inflammation, and some other tumors can show uptake. Conversely, small lesions and tumors with low PSMA expression may be missed. Treatment timing can change uptake. The report must therefore be correlated with PSA, pathology, prior imaging, and the clinical question.
Preparation and radiation precautions are radiopharmaceutical- and protocol-specific. Tell the department before the tracer is given if you are or may be pregnant, are breastfeeding, care for a young child, or recently had another nuclear-medicine test. Do not stop medicines, fast, interrupt breastfeeding, or follow a fixed distancing period based only on a general webpage; obtain written instructions for the exact tracer, activity, and examination from the nuclear-medicine team.
Questions to ask your nuclear-medicine team
- Which radiopharmaceutical and protocol will be used, and what clinical question should the study answer?
- What exact fasting, hydration, medicine, diabetes, pregnancy, or breastfeeding instructions apply to me?
- Will CT be included, will contrast be used, and how does that change preparation and radiation exposure?
- What written precautions apply afterward, when will the signed report be ready, and who will explain any next step?
Sources and further reading
- RadiologyInfo.org: General nuclear medicine
- RadiologyInfo.org: Preparing for a nuclear-medicine examination
- IAEA: Basics of quality management for nuclear medicine practices
Conclusion
A PSMA PET/CT can materially improve staging or recurrence assessment in selected patients, but it is not infallible and does not replace clinical, laboratory, and pathological correlation. Follow the center's tracer-specific preparation and aftercare instructions.